BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 19617789)

  • 1. Long-term results of topical mitomycin C 0.02% for primary and recurrent conjunctival-corneal intraepithelial neoplasia.
    Ballalai PL; Erwenne CM; Martins MC; Lowen MS; Barros JN
    Ophthalmic Plast Reconstr Surg; 2009; 25(4):296-9. PubMed ID: 19617789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitomycin C treatment for conjunctival-corneal intraepithelial neoplasia: a multicenter experience.
    Frucht-Pery J; Sugar J; Baum J; Sutphin JE; Pe'er J; Savir H; Holland EJ; Meisler DM; Foster JA; Folberg R; Rozenman Y
    Ophthalmology; 1997 Dec; 104(12):2085-93. PubMed ID: 9400769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical 0.002% mitomycin C for the treatment of conjunctival-corneal intraepithelial neoplasia and squamous cell carcinoma.
    Prabhasawat P; Tarinvorakup P; Tesavibul N; Uiprasertkul M; Kosrirukvongs P; Booranapong W; Srivannaboon S
    Cornea; 2005 May; 24(4):443-8. PubMed ID: 15829803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of recurrent corneal and conjunctival intraepithelial neoplasia with topical interferon alfa 2b.
    Boehm MD; Huang AJ
    Ophthalmology; 2004 Sep; 111(9):1755-61. PubMed ID: 15350333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of surgical wide excision and amniotic membrane transplantation with adjuvant topical mitomycin C treatment in recurrent conjunctival--corneal intraepithelial neoplasia.
    Lee JH; Kim YH; Kim MS; Kim EC
    Semin Ophthalmol; 2014 Jul; 29(4):192-5. PubMed ID: 23971714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of ocular surface squamous neoplasia with Mitomycin C.
    Gupta A; Muecke J
    Br J Ophthalmol; 2010 May; 94(5):555-8. PubMed ID: 20447963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limbal stem cell deficiency following topical mitomycin C treatment of conjunctival-corneal intraepithelial neoplasia.
    Dudney BW; Malecha MA
    Am J Ophthalmol; 2004 May; 137(5):950-1. PubMed ID: 15126170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of recurrent corneal intraepithelial neoplasia with topical mitomycin C.
    Tseng SH; Tsai YY; Chen FK
    Cornea; 1997 Sep; 16(5):595-7. PubMed ID: 9294697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of mitomycin C in the treatment of corneal conjunctival intraepithelial neoplasia.
    Daniell M; Maini R; Tole D
    Clin Exp Ophthalmol; 2002 Apr; 30(2):94-8. PubMed ID: 11886411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitomycin C therapy for conjunctival-corneal intraepithelial neoplasia.
    Papandroudis AA; Dimitrakos SA; Stangos NT
    Cornea; 2002 Oct; 21(7):715-7. PubMed ID: 12352093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical mitomycin C for extensive, recurrent conjunctival-corneal squamous cell carcinoma.
    Shields CL; Naseripour M; Shields JA
    Am J Ophthalmol; 2002 May; 133(5):601-6. PubMed ID: 11992855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical mitomycin C for the treatment of conjunctival and corneal epithelial dysplasia and neoplasia.
    Wilson MW; Hungerford JL; George SM; Madreperla SA
    Am J Ophthalmol; 1997 Sep; 124(3):303-11. PubMed ID: 9439356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of conjunctiva-cornea intraepithelial neoplasia successfully treated with topical mitomycin C and interferon alfa-2b in cycles.
    Di Pascuale MA; Espana EM; Tseng SC
    Cornea; 2004 Jan; 23(1):89-92. PubMed ID: 14701965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of conjunctival corneal intraepithelial neoplasia with topical mitomycin C.
    Haas K; Ben-Dor D; Levartovsky S
    Arch Ophthalmol; 1999 Apr; 117(4):544-5. PubMed ID: 10206591
    [No Abstract]   [Full Text] [Related]  

  • 15. Randomized controlled trial of topical mitomycin C for ocular surface squamous neoplasia: early resolution.
    Hirst LW
    Ophthalmology; 2007 May; 114(5):976-82. PubMed ID: 17241666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of conjunctival and corneal epithelial neoplasia with retinoic acid and topical interferon alfa-2b: long-term follow-up.
    Krilis M; Tsang H; Coroneo M
    Ophthalmology; 2012 Oct; 119(10):1969-73. PubMed ID: 22704834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of diffuse ocular surface squamous neoplasia: efficacy and complications of topical chemotherapy.
    Rudkin AK; Dempster L; Muecke JS
    Clin Exp Ophthalmol; 2015; 43(1):20-5. PubMed ID: 24995542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term follow-up of conjunctival and corneal intraepithelial neoplasia treated with topical interferon alfa-2b.
    Schechter BA; Koreishi AF; Karp CL; Feuer W
    Ophthalmology; 2008 Aug; 115(8):1291-6, 1296.e1. PubMed ID: 18187195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-Fluorouracil for the treatment of intraepithelial neoplasia of the conjunctiva and cornea.
    Yeatts RP; Engelbrecht NE; Curry CD; Ford JG; Walter KA
    Ophthalmology; 2000 Dec; 107(12):2190-5. PubMed ID: 11097594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of conjunctival intraepithelial neoplasia with topical mitomycin C 0.02%].
    Ramos-López JF; Martínez-Costa Pérez R; Cisneros Lanuza AL; Francés Muñoz E; Monte Boque E; Muñoz Gómez MC; López-Sánchez EV; Menezo Rozalén JL
    Arch Soc Esp Oftalmol; 2004 Aug; 79(8):375-8. PubMed ID: 15306963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.